(Q42999030)

12 November 2017

Microarray analyses and molecular profiling of Stat3 signaling pathway induced by hepatitis C virus core protein in human hepatocytes (English)

1 reference

12 November 2017

1 reference

1 reference

Adrian M. Di Bisceglie

5

object named as

Adrian M Di Bisceglie

1 reference

12 November 2017

7

Ratna B Ray

1 reference

12 November 2017

Arnab Basu

1

1 reference

12 November 2017

Keith Meyer

2

1 reference

12 November 2017

Keith K Lai

3

1 reference

12 November 2017

Kousuke Saito

4

1 reference

12 November 2017

Leonard E Grosso

6

1 reference

12 November 2017

Ranjit Ray

8

1 reference

12 November 2017

language of work or name

English

0 references

publication date

20 March 2006

1 reference

12 November 2017

1 reference

12 November 2017

349

1 reference

12 November 2017

347-358

1 reference

12 November 2017

2

1 reference

CC-chemokine receptor 5 (CCR5) in hepatitis C--at the crossroads of the antiviral immune response?

12 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.02.023

Epidemiology of hepatitis C in the West

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.02.023

Hepatitis C virus core protein is necessary for the maintenance of immortalized human hepatocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.02.023

Transcriptional Activation of the Interleukin-2 Promoter by Hepatitis C Virus Core Protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.02.023

The Bcl-2 protein family: sensors and checkpoints for life-or-death decisions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.02.023

Epidemiology of primary liver cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.02.023

Activation and association of Stat3 with Src in v-Src-transformed cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.02.023

Leptin stimulates tissue inhibitor of metalloproteinase-1 in human hepatic stellate cells: respective roles of the JAK/STAT and JAK-mediated H2O2-dependant MAPK pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.02.023

Validating Stat3 in cancer therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.02.023

Silencing of integrated human papillomavirus type 18 oncogene transcription in cells expressing SerpinB2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.02.023

Hepatitis C virus core protein induces cell proliferation and activates ERK, JNK, and p38 MAP kinases together with the MAP kinase phosphatase MKP-1 in a HepG2 Tet-Off cell line

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.02.023

Steatosis and intrahepatic hepatitis C virus in chronic hepatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.02.023

Apoptosis and expression of Bcl-2, Bcl-XL, and Bax in renal cell carcinomas.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.02.023

Kaposi's Sarcoma-associated herpesvirus open reading frame 50 stimulates the transcriptional activity of STAT3.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.02.023

Expression of the CXCR3 ligand I-TAC by hepatocytes in chronic hepatitis C and its correlation with hepatic inflammation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.02.023

Metabolic aspects of hepatitis C viral infection: steatohepatitis resembling but distinct from NASH.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.02.023

Risk factors for recurring hepatocellular carcinoma differ according to infected hepatitis virus-an analysis of 236 consecutive patients with a single lesion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.02.023

Hepatitis C virus infection activates the immunologic (type II) isoform of nitric oxide synthase and thereby enhances DNA damage and mutations of cellular genes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.02.023

Nonenveloped Nucleocapsids of Hepatitis C Virus in the Serum of Infected Patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.02.023

Elevation of interleukin 6 levels in patients with chronic hepatitis due to hepatitis C virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.02.023

The proto-oncoprotein c-Fos negatively regulates hepatocellular tumorigenesis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.02.023

Hepatitis C virus core protein exerts an inhibitory effect on suppressor of cytokine signaling (SOCS)-1 gene expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.02.023

Hepatitis C virus core protein induces hepatic steatosis in transgenic mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.02.023

The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.02.023

Deregulation of cyclin E2 expression and associated kinase activity in primary breast tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.02.023

Hepatitis C virus core protein: intriguing properties and functional relevance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.02.023

Hepatitis C virus core protein promotes immortalization of primary human hepatocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.02.023

Hepatitis C virus infection is associated with the development of hepatocellular carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.02.023

Human leptin signaling in human peripheral blood mononuclear cells: activation of the JAK-STAT pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.02.023

Transforming growth factor-beta1 downregulation of Smad1 gene expression in rat hepatic stellate cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.02.023

An update on the molecular genetics of hepatocellular carcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.02.023

Viral and immunological determinants of hepatitis C virus clearance, persistence, and disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.02.023

Suppression of hepatitis C virus by hepatitis B virus in coinfected patients at the National University Hospital of Singapore

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.02.023

The JAK-STAT pathway: signal transduction involved in proliferation, differentiation and transformation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.02.023

Predicting hepatitis B virus-positive metastatic hepatocellular carcinomas using gene expression profiling and supervised machine learning

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.02.023

Activation of STAT3 by the Hepatitis C Virus Core Protein Leads to Cellular Transformation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.02.023

The STATs of cancer--new molecular targets come of age

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.02.023

10.1016/J.VIROL.2006.02.023

7 January 2021

Identifiers

DOI

1 reference

12 November 2017

1 reference